Detection and prevalence of carbapenem-resistant Gram-negative bacteria among European laboratories part of the COMBACTE network: a COMBACTE LAB-Net survey

Antimicrobial resistance (AMR) causes numerous deaths in Europe and around the world, diminishes quality of life, and threatens to reverse many of the enormous strides modern medicine has made over the last century. Unless action is taken, some estimate that by 2050, up to ten million additional lives will be lost prematurely each because of AMR [1,2]. Prudent use of existing antibiotics and acceleration of development of new antimicrobial agents are desperately needed in order to preserve the effectiveness of these “wonder drugs”.

Source: International Journal of Antimicrobial Agents - November 1, 2018 Category: Drugs & Pharmacology Authors: T Kostyanev, T Vilken, C Lammens, L Timbermont, A van't Veen, H Goossens Source Type: research